NCT03739294View on ClinicalTrials.gov

Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 8, 2019

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Pharmacokinetics
Interventions
DRUG

Fluticasone Furoate/ Vilanterol Trifenatate

Asthma inhalation medication

Trial Locations (1)

2400

Respiratory research unit, Bispebjerg University Hospital, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Bispebjerg Hospital

OTHER

NCT03739294 - Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate | Biotech Hunter | Biotech Hunter